PharmID, Inc. — Form D
PharmID, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2018-07-26. The offering totals $3.0M, of which $383K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-07-26
- Form: D
- Accession: 0001719289-18-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $383K
- Remaining: $2.6M
- Investors: 4
- Date of first sale: 2018-07-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-317795
Issuer
- Name: PharmID, Inc.
- CIK: 0001719289
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 2157 N. NORTHLAKE WAY #240, SEATTLE, WA, 98103
- Phone: 206-992-3589
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Tim Gibbons | Director | Seattle, WA |
| Scott Van Vuren | Director | Seattle, WA |
| Tim Gibbons | Executive Officer | Seattle, WA |
| Brian Marquardt | Director | Seattle, WA |
| Brian Marquardt | Executive Officer | Seattle, WA |
| Christopher Swasand | Director | Seattle, WA |
| Tom Pierson | Executive Officer | Seattle, WA |
| J. Scott Van Vuren | Director | Seattle, WA |
| J. Scott Van Vuren | Executive Officer | Seattle, WA |
Other filings by this issuer (2)
More